Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001493152-24-000298
Filing Date
2024-01-03
Accepted
2024-01-03 16:22:52
Documents
10

Document Format Files

Seq Description Document Type Size
1 form424b2.htm 424B2 712748
2 ex107.htm EX-FILING FEES 8288
3 form424b2_001.jpg GRAPHIC 38603
4 form424b2_003.jpg GRAPHIC 26954
5 form424b2_004.jpg GRAPHIC 28331
6 form424b2_005.jpg GRAPHIC 21401
7 form424b2_006.jpg GRAPHIC 21967
8 form424b2_007.jpg GRAPHIC 20895
9 form424b2_008.jpg GRAPHIC 4701
10 form424b2_002.jpg GRAPHIC 9283
  Complete submission text file 0001493152-24-000298.txt   957958
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-271542 | Film No.: 24506836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)